Sponsored by:

Molecular Imaging: Page 316

BSGI more sensitive than ultrasound, mammography
By Kate Madden Yee
Monday, November 28 | 10:10 a.m.-10:20 a.m. | MSVM21-08 | Arie Crown TheaterBreast-specific gamma imaging (BSGI) has greater sensitivity and comparable specificity compared with ultrasound and mammography, according to researchers at the Hospital of Central Connecticut, and it could be a valuable additional procedure when these imaging modalities fail to provide a clear diagnosis.
November 8, 2011
Low-dose MBI works just as well in dense breast tissue
By Kate Madden Yee
Monday, November 28 | 9:50 a.m.-10:00 a.m. | MSVM21-07 | Arie Crown TheaterLow-dose molecular breast imaging (MBI) is just as sensitive as conventional-dose MBI in detecting cancers in dense breast tissue mammography misses, according to researchers at the Mayo Clinic in Rochester, MN.
November 8, 2011
Int'l Isotopes teams with Idaho State for copper-67
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes has inked an agreement in principle with Idaho State University to jointly develop processes to produce copper-67, an isotope with potential for treating non-Hodgkin's lymphoma and bladder, colorectal, and ovarian cancers.
November 7, 2011
Road to RSNA 2011: Molecular Imaging Preview
By Wayne Forrest
At this year's annual RSNA meeting, the advance of hybrid imaging and the development of new imaging agents are expected to be among the most intriguing developments in molecular imaging and nuclear medicine in Chicago.
November 7, 2011
Road to RSNA 2011: Molecular Imaging Preview
MRI protocol developed for attenuation correction in PET/MRI for head and neck cancer
By Wayne Forrest
Wednesday, November 30 | 10:50 a.m.-11:00 a.m. | SSK13-03 | Room S505ABGerman researchers are developing a potential MRI protocol for use in a PET/MRI system to handle whole-body attenuation correction and diagnostic sequences for staging head and neck cancer patients.
November 7, 2011
FDG-PET/CT study helps detect brain changes from chemotherapy
By Wayne Forrest
Tuesday, November 29 | 3:50 p.m.-4:00 p.m. | SSJ19-06 | Room S505ABFDG-PET/CT may be a beneficial diagnostic tool to document cognitive decline, or "chemo brain," in breast cancer patients receiving chemotherapy, according to a study from West Virginia University Hospitals.
November 7, 2011
FDG-PET metabolic parameters help differentiate severity of brain tumors
By Wayne Forrest
Tuesday, November 29 | 3:20 p.m.-3:30 p.m. | SSJ19-03 | Room S505ABIn this presentation, researchers will discuss how standardized uptake values and glucose metabolic rates can help differentiate between tumors and benign lesions when evaluating patients with central nervous system lesions with FDG-PET.
November 7, 2011
Fused PET/MRI tops MR spectroscopy in brain tumor recurrence
By Wayne Forrest
Tuesday, November 29 | 3:00 p.m.-3:10 p.m. | SSJ19-01 | Room S505ABA study from the University of California, San Diego has found fused FDG-PET/MRI to be more sensitive, specific, and accurate than MR spectroscopy in detecting the recurrence of primary and metastatic brain tumors in patients with a history of grade III or IV brain tumors.
November 7, 2011
Choline-PET/CT in recurrent prostate cancer cases could alter therapy
By Wayne Forrest
Tuesday, November 29 | 11:50 a.m.-12:00 p.m. | SSG12-09 | Room S505ABCholine-PET/CT can greatly affect therapy management for recurrent prostate cancer patients and should be considered for restaging, according to a new study by Swiss researchers.
November 7, 2011
Novel tracer shows early promise for brain tumor imaging
By Wayne Forrest
Tuesday, November 29 | 11:40 a.m.-11:50 a.m. | SSG08-08 | Room S504CDIn this scientific paper presentation, researchers from Washington University School of Medicine will present their work on a novel synthesized tracer that so far has shown promising tumor imaging properties in the potential to complement MRI for evaluating patients with primary and metastatic brain tumors.
November 7, 2011
Ga-68 DOTA-NOC tops F-18 DOPA-PET/CT for neuroendocrine tumors
By Wayne Forrest
Tuesday, November 29 | 10:50 a.m.-11:00 a.m. | SSG12-03 | Room S505ABIn a comparison with F-18 DOPA-PET/CT, gallium-68 (Ga-68) DOTA-NOC achieved "superior sensitivity" with neuroendocrine tumors, prompting researchers to conclude that Ga-68 DOTA-NOC could help direct more effective patient treatment.
November 7, 2011
Researchers look for link between veterans' motor issues and brain injuries
By Wayne Forrest
Monday, November 28 | 3:20 p.m.-3:30 p.m. | SSE19-03 | Room S505ABWith the help of FDG-PET, researchers at the University of Washington are investigating a possible link between Parkinsonian motor symptoms and blast-related mild traumatic brain injury among Iraq and Afghanistan war veterans.
November 7, 2011
Previous Page
Page 316 of 612
Next Page